• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

An un-dopamine hypothesis of schizophrenia.

作者信息

Alpert M, Friedhoff A J

出版信息

Schizophr Bull. 1980;6(3):387-9. doi: 10.1093/schbul/6.3.387.

DOI:10.1093/schbul/6.3.387
PMID:6105705
Abstract

The dopamine hypothesis of schizophrenia is examined critically. Although the hypothesis is couched in chemical terms, the evidence is primarily pharmacologic. In addition, neuroleptic mechanisms do not fit a simple hyperdopaminergic formulation, and treatment efficacy points to a general psychotic rather than specific schizophrenic role for dopamine. Most compromising to the hypothesis is the therapeutic action of L-dopa when combined with neuroleptics in chronic schizophrenics. Dopamine appears important but cannot be viewed as a simple pathogen.

摘要

相似文献

1
An un-dopamine hypothesis of schizophrenia.
Schizophr Bull. 1980;6(3):387-9. doi: 10.1093/schbul/6.3.387.
2
Dopamine receptors and the dopamine hypothesis of schizophrenia.多巴胺受体与精神分裂症的多巴胺假说
Synapse. 1987;1(2):133-52. doi: 10.1002/syn.890010203.
3
Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.精神分裂症患者的抗精神病药物治疗。作用机制及临床意义。
Br J Psychiatry Suppl. 1994 Apr(23):65-70.
4
Loss of the Kamin blocking effect in acute but not chronic schizophrenics.急性而非慢性精神分裂症患者中卡明阻断效应的丧失。
Biol Psychiatry. 1992 Nov 1;32(9):739-55. doi: 10.1016/0006-3223(92)90078-e.
5
Neuroleptics, dopamine, and schizophrenia.抗精神病药物、多巴胺与精神分裂症
Psychiatr Clin North Am. 1986 Mar;9(1):35-48.
6
Neuroleptics and psychic indifference: a review.抗精神病药物与精神淡漠:综述
J R Soc Med. 1989 Oct;82(10):615-9. doi: 10.1177/014107688908201018.
7
The dopamine hypothesis of schizophrenia revisited.再探精神分裂症的多巴胺假说。
Psychoneuroendocrinology. 1979 Jan;4(1):37-46. doi: 10.1016/0306-4530(79)90039-8.
8
The dopamine hypothesis of schizophrenia: current status, future prospects.精神分裂症的多巴胺假说:现状与未来展望
Int Clin Psychopharmacol. 1997 Nov;12(6):297-308. doi: 10.1097/00004850-199711000-00002.
9
Problems in classification of schizophrenics as neuroleptic responders and nonresponders.将精神分裂症患者分类为抗精神病药物反应者和无反应者的问题。
J Nerv Ment Dis. 1985 Jun;173(6):325-31. doi: 10.1097/00005053-198506000-00001.
10
New insights into schizophrenia through atypical antipsychotic drugs.通过非典型抗精神病药物对精神分裂症的新见解。
Neuropsychopharmacology. 1988 Sep;1(3):193-6. doi: 10.1016/0893-133x(88)90015-2.

引用本文的文献

1
A study of physical anhedonia as a trait marker in schizophrenia.一项关于将躯体快感缺失作为精神分裂症特质标志物的研究。
Ind Psychiatry J. 2018 Jul-Dec;27(2):235-239. doi: 10.4103/ipj.ipj_65_17.
2
Impaired Prefrontal Cortical Dopamine Release in Schizophrenia During a Cognitive Task: A [11C]FLB 457 Positron Emission Tomography Study.精神分裂症患者认知任务时前额叶皮质多巴胺释放减少:一项 [11C]FLB 457 正电子发射断层扫描研究。
Schizophr Bull. 2019 Apr 25;45(3):670-679. doi: 10.1093/schbul/sby076.
3
Negative symptoms: psychopathological models.阴性症状:精神病理学模型
J Psychiatry Neurosci. 1991 Mar;16(1):12-8.
4
[Use of low doses of bromocriptine in chronic schizophrenia resistant to neuroleptics. A preliminary study].[低剂量溴隐亭用于对抗精神病药物耐药的慢性精神分裂症。一项初步研究]
J Psychiatry Neurosci. 1992 Jun;17(2):68-71.